During the last session, SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s traded shares were 0.9 million, with the beta value of the company hitting 0.86. At the end of the trading day, the stock’s price was $45.53, reflecting an intraday gain of 3.01% or $1.33. The 52-week high for the SWTX share is $53.92, that puts it down -18.43 from that peak though still a striking 60.47% gain since the share price plummeted to a 52-week low of $18.00. The company’s market capitalization is $3.36B, and the average trade volume was 1.13 million shares over the past three months.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
SpringWorks Therapeutics Inc (SWTX) registered a 3.01% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.01% in intraday trading to $45.53, hitting a weekly high. The stock’s 5-day price performance is 13.54%, and it has moved by -9.12% in 30 days. Based on these gigs, the overall price performance for the year is 95.83%.
SpringWorks Therapeutics Inc (SWTX) estimates and forecasts
Statistics show that SpringWorks Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. SpringWorks Therapeutics Inc (SWTX) shares have gone up 105.18% during the last six months, with a year-to-date growth rate less than the industry average at 8.93% against 12.90. In the rating firms’ projections, revenue will increase 1,520.50% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 12.21M as predicted by 7 analyst(s). Meanwhile, a consensus of 7 analyst(s) estimates revenue growth to 19.89M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -65.72%. While earnings are projected to return 9.24% in 2024.
SWTX Dividends
SpringWorks Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
